Cite
MLA Citation
I Monge et al.. “4CPS-024 Efficacy, safety and acceptance of treatment with alirocumab or evolocumab in patients with dyslipidaemia.” European journal of hospital pharmacy, vol. 26, n.d., pp. A78–A79. http://access.bl.uk/ark:/81055/vdc_100135142225.0x000001